在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

CYP2B6 Antibody

  • 中文名稱:
    CYP2B6兔多克隆抗體
  • 貨號:
    CSB-PA006414LA01HU
  • 規(guī)格:
    ¥440
  • 圖片:
    • Immunohistochemistry of paraffin-embedded human liver tissue using CSB-PA006414LA01HU at dilution of 1:100
    • Immunofluorescent analysis of MCF-7 cells using CSB-PA006414LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品名稱:
    Rabbit anti-Homo sapiens (Human) CYP2B6 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    CYP2B6
  • 別名:
    1,4 cineole 2 exo monooxygenase antibody; 11B1 antibody; CP2B6_HUMAN antibody; CPB 6 antibody; CPB6 antibody; CYP 2B6 antibody; CYP IIB6 antibody; CYP2B antibody; CYP2B6 antibody; CYP2B7 antibody; CYP2B7P antibody; CYPIIB6 antibody; Cytochrome P450 2B6 antibody; Cytochrome P450 family 2 subfamily B antibody; Cytochrome P450 family 2 subfamily B polypeptide 6 antibody; Cytochrome P450 IIB1 antibody; Cytochrome P450 phenobarbital inducible antibody; Cytochrome P450 subfamily IIB (phenobarbital inducible) antibody; Cytochrome P450 subfamily IIB (phenobarbital inducible) polypeptide 6 antibody; Cytochrome P450 subfamily IIB polypeptide 6 antibody; EFVM antibody; IIB1 antibody; P450 antibody; P450 IIB1 antibody; P450IIB1 antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human
  • 免疫原:
    Recombinant Human Cytochrome P450 2B6 protein (250-343AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    Non-conjugated

    本頁面中的產(chǎn)品,CYP2B6 Antibody (CSB-PA006414LA01HU),的標(biāo)記方式是Non-conjugated。對于CYP2B6 Antibody,我們還提供其他標(biāo)記。見下表:

    可提供標(biāo)記
    標(biāo)記方式 貨號 產(chǎn)品名稱 應(yīng)用
    HRP CSB-PA006414LB01HU CYP2B6 Antibody, HRP conjugated ELISA
    FITC CSB-PA006414LC01HU CYP2B6 Antibody, FITC conjugated
    Biotin CSB-PA006414LD01HU CYP2B6 Antibody, Biotin conjugated ELISA
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA, IHC, IF
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:20-1:200
    IF 1:50-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

  • 功能:
    A cytochrome P450 monooxygenase involved in the metabolism of endocannabinoids and steroids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Hydroxylates steroid hormones, including testosterone at C-16 and estrogens at C-2. Plays a role in the oxidative metabolism of xenobiotics, including plant lipids and drugs. Acts as a 1,4-cineole 2-exo-monooxygenase.; Allele 2B6*9: Has low affinity for anandamide and can only produce 11,12 EpETrE-EAs.
  • 基因功能參考文獻(xiàn):
    1. Case Reports: CYP2B6-deficient alleles may be responsible for an increased conversion of ifosfamide into neurotoxic metabolites, leading to encephalopathy. PMID: 29319893
    2. The concentration-time curve (AUC(0(R)96)), maximum plasma concentration (Cmax), and terminal half-life (t1/2) values of Bupropion in CYP2B6*1/*4 were lower than those of CYP2B6*1/*1. The hydroxybupropion (HBUP) Cmax values in CYP2B6*4/*6 and CYP2B6*1/*4 increased by 1.12-fold and 1.97-fold, whereas the HBUP Cmax value in CYP2B6*1/*6 decreased to a value 1.64-fold lower than that in CYP2B6*1/*1 PMID: 29637923
    3. CYP2B6-efavirenz analog complex provides a useful platform to investigate computationally as well as biophysically the effect of genetic polymorphisms on binding of the widely studied efavirenz. PMID: 29596329
    4. results indicate that the amino acid substitutions in the CYP2B6 variants suppressed the metabolic activation of CPS. CYP2B6 variants have altered capacity to bioactivate CPF and may affect individual susceptibility of CPF PMID: 29463407
    5. The findings of this study indicate that CYP2B6 contribute to the metabolism of MDMA to MDA in humans PMID: 28117133
    6. The first data of several CYP2B6 polymorphisms in Roma population. PMID: 29095103
    7. With consensus recommendations on downregulation, CYP2C induction, and CYP2B6 positive control. PMID: 28646080
    8. Genotyping of CYP2B6 may therefore be of value when assessing dose requirements in methadone maintenance treatment. PMID: 28723731
    9. Genomic variation in CYP2B6 may explain, at least in part, severity of Neonatal Abstinence Syndrome PMID: 28320034
    10. CYP2B6 haplotype predicts efavirenz plasma concentration in black South African HIV-1-Infected children. PMID: 28816644
    11. This is the first study that investigated the impact of the 516 G>T polymorphism of the CYP2B6 gene among HIV-positive individuals from southern Brazil. Its clinical significance indicates the need for prospective studies in this population. PMID: 28492729
    12. G(516)T CYP2B6 polymorphisms was associated with Bronchopulmonary Dysplasia susceptibility in Preterm Neonates. PMID: 28081574
    13. The deficient CYP2B6 516 T allele is associated with higher efavirenz plasma drug levels and more frequent central nervous system-related symptoms. PMID: 28145050
    14. Males with the CYP2B6 *6/*6 genotype may be less susceptible to the development of anti-tuberculosis drug-induced hepatotoxicity. PMID: 28389387
    15. CYP2B6 interindividual variability was not significantly associated with genetic variation in CYP2B6, nor was it associated with differences in gender or ethnicity, suggesting that factors other than these are largely responsible for the wide range of variability in CYP2B6 expression and activity observed among a large group of individuals/samples. PMID: 26608082
    16. Established the regression models for CYP3A4 and CYP2B6 inductions in human hepatocytes using azole compounds. PMID: 27208383
    17. Phe206 plays a crucial role in determining the specificity of CYP2B6. PMID: 27538916
    18. Homozygous carriers of CYP2B6*6 allele may be at increased risk for EFV-induced QT interval prolongation via inhibition of hERG. PMID: 27333947
    19. Genetic variations in CYP2B6 affect induction of Bupropion hydroxylation by sodium ferulate. PMID: 23840296
    20. CYP2B6 SNPs are associated with methadone fatalities. contributes to a poor metabolizer phenotype for methadone in these fatal cases PMID: 28184434
    21. CYP2B6 rs2279343 may predict event-free survival in rhabdomyosarcoma PMID: 27388155
    22. It has been established that cytochrome P4502B6 (CYP2B6) is the major isoform catalyzing both ketamine N-demethylation and ketamine metabolism overall in vitro at therapeutic concentrations and clinically. PMID: 27763887
    23. polymorphism c.516G>T in the CYP2B6 gene and BMI affect the metabolism rate of propofol and may play an important role in the optimisation of propofol anaesthesia PMID: 27826892
    24. his cross-sectional, pharmacogenetic candidate, gene pilot study recruited 75 patients having minor elective outpatient surgeries. EP was measured with the Clinician Administered Dissociative State Scale. Genetic association of CYP2B6*6 and GRIN2B (rs1019385 and rs1806191) single-nucleotide polymorphisms and ketamine-induced EP occurrence and severity were tested using logistic and linear regression. PMID: 28252572
    25. Data suggest that A785G CYP2B6 gene polymorphisms and specific CYP2B6 haplotypes may be a risk factor for the pathogenesis of AML, especially secondary AML as well as for the induction of AML chromosomal aberrations. PMID: 27865701
    26. Results show that CYP2B6 slow metabolizer genotypes were significantly associated with efavirenz induced central nervous system symptoms. PMID: 27509478
    27. The possible influence of CYP2B6 c.516G>T genetic variant on propofol dose. PMID: 26141406
    28. Around 450 and 250 mg daily doses might meet EFV dosing needs of HIV-TB infected Ugandans in general and CYP2B6*6/*6 genotypes, respectively. PMID: 27045425
    29. CYP2B6 polymorphisms were associated with lower and higher plasma concentrations in pregnant and postpartum women. PMID: 27195527
    30. Analysis of gene-gene interactions with CYP2B6 was particularly useful to reinforce the role of MRP4 and to reveal unknown associations, such as that of DRD3. PMID: 27665700
    31. POR rs2868177 and CYP2B6*6 variants contribute to the interindividual variability in human CYP2B6 activity, which may affect the disposition and interaction of other CYP2B6 substrate drugs PMID: 27439448
    32. CYP2B6*6 and *9 variant alleles had a significant decreasing effect on sertraline metabolism in major depression patients. PMID: 26830411
    33. Combined 3D-QSAR and docking procedures yielded precise information about the common and distinct interactions of inhibitors and the enzyme active sites of CYP2B6. PMID: 26648056
    34. the cytochrome P450 oxidoreductase g.6593A>G polymorphism significantly influences CYP2B6 activity PMID: 26580670
    35. Observation in Chinese patients with systemic lupus erythematosus indicated that the combination genetic marker of CYP2C19*2 and CYP2B6 -750 T > C genotypes was associated with 4-OH-CPA plasma concentration, short term efficacy and adverse reactions of cyclophosphamide. PMID: 26456622
    36. Data suggest that primary cytochrome P450 in liver microsomes catalyzing 9-hydroxylation of (-)-cis- and (-)-trans-rose oxide is CYP2B6 (and CYP2C19 to some extent); rose oxide is aroma compound from essential oils and is used in food and perfume. PMID: 26126958
    37. CYP2B6 516G>T SNP is prevalent in Aregntinian population. PMID: 26681005
    38. Both Cyp2b6 CT/TT genotype of rs8192719 (c.1294 + 3C > T) and AG genotype of rs2279343 (c.785A > G) prolonged survival (p < 0.05). PMID: 26602960
    39. Data suggest peripheral ligand-binding pocket and active site are located on opposite sides of the I-helix in CYP2B6; similar results were obtained for CYP2B4. PMID: 26982502
    40. Report shift in substrate specificity with sequence element swaps between CYP2B6 and CYP2B11. PMID: 27015760
    41. gene expression experiment revealed that CYP2B6, SPON1, and GSG1L can be activated concomitantly through a constitutive androstane receptor (CAR) activation pathway PMID: 27010727
    42. POR besides CYP2B6 can influence cyclophosphamide metabolism PMID: 26544874
    43. The CYP2B6*6 allele is associated with decrease plasma clearance and may be associated with a higher incidence of ketamine adverse effects. PMID: 25702819
    44. Average efavirenz concentrations of patients carrying ACTG (1.78 mug/mL), ACCT (7.50 mug/mL), and ATTG (1.92 mug/mL) haplotypes were markedly higher than those of patients carrying the CCTG haplotype. PMID: 26107645
    45. CYP2B6 Gene Polymorphism is not associated with Acute Myeloid Leukemia. PMID: 26107207
    46. The results provide evidence that the 516 TT homozygous genotype in the CYP2B6 gene presents a significant protective effect on the development of liver toxicity caused by anti-tuberculosis drugs. PMID: 25271170
    47. Studied the extent to which CYP2B6 and NAT2 polymorphisms were associated increased efavirenz concentrations in black and Hispanic patients enrolled from sub-Saharan Africa and South America. PMID: 25722197
    48. An increase in minor allele frequencies for CYP2B6 (and CYP2D6)was found in Roma population samples. PMID: 25933954
    49. significantly reduce the success of autologous HCT for lymphoma patients with the CYP2B6*5 variant. PMID: 25677220
    50. Functional importance of a peripheral pocket in mammalian cytochrome P450 2B enzymes. PMID: 26319176

    顯示更多

    收起更多

  • 亞細(xì)胞定位:
    Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.
  • 蛋白家族:
    Cytochrome P450 family
  • 組織特異性:
    Expressed in liver, lung and heart right ventricle.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 2615

    OMIM: 123930

    KEGG: hsa:1555

    STRING: 9606.ENSP00000324648

    UniGene: Hs.1360



主站蜘蛛池模板: 欧美欧洲成本大片免费| 国产在线无码一区二区三区视频| 成人av无码一区二区三区| 刺激性视频黄页| 午夜精品久久久久久中宇| 成人欧美一区二区三区黑人免费| 狠狠躁夜夜躁无码中文字幕| 精品无码国产自产在线观看水浒传 | 久久综合香蕉国产蜜臀av| 精品国产18久久久久久| 久久精品国产99久久丝袜蜜桃| 首页 国产 亚洲 丝袜图片区| 99精品国产一区二区三区不卡| 欧美一区二区三区成人久久片| 自慰系列无码专区| 亚洲中文字幕人成乱码| 国产在线永久视频| 久久婷婷五月综合色一区二区| 国产xxxx69真实实拍| 国产女主播白浆在线看| 精品国内在视频线2019| 黄瓜视频在线观看| 亚洲中文字幕无码中文| 久久精品视频在线看| 欧美激情在线播放| 女人张开双腿让男人猛桶| 亚洲性av网站| 四虎国产精品永久在线观看| 亚洲熟妇色xxxxx欧美老妇| 欧美精品黑人粗大| 免费做爰猛烈吃奶摸视频在线观看| 丰满人妻一区二区三区视频53| 亚洲欧洲日本无在线码| 亚洲一区二区三区高清在线看| 99精品视频在线观看免费| 国产真实乱人偷精品视频| 日日碰日日摸夜夜爽无码| 精品卡一卡二卡3卡高清乱码| 国产精品久久久久久| 亚洲精品一本之道高清乱码| 久久久99久久久国产自输拍|